Metric Finance
LearnFAQ
LearnFAQ

Learn / WGS

NASDAQ: WGS

GeneDx Holdings (WGS) stock, explained like you're 5

GeneDx Holdings trades on the Nasdaq under the ticker WGS. It is a mid cap company in the medical/nursing services industry, part of the healthcare sector, with a market value of about 2 billion dollars.

Ticker
WGS
Exchange
Nasdaq
Sector
Healthcare
Industry
Medical/Nursing Services
Size
Mid cap, about 2 billion dollars

Is GeneDx Holdings a small, medium or large cap company?

No. GeneDx Holdings is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 2 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How GeneDx Holdings makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves WGS stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • GeneDx Holdings And 2 Other Top Healthcare Stocks (Yahoo Finance)
  • GeneDx Holdings (NasdaqGS:WGS) Stock Forecast & Analyst Predictions (Simply Wall Street)
  • WGS Oct 2026 77.000 call (WGS261023C00077000) stock price, news, quote and history (Yahoo Finance UK)
  • WGS Oct 2026 69.000 call (WGS261023C00069000) stock price, news, quote and history (Yahoo Finance UK)
  • WGS Oct 2026 95.000 call (WGS261023C00095000) stock price, news, quote and history (Yahoo Finance Australia)

Follow WGS in your daily brief

Each trading day at 5 PM ET we post what happened to GeneDx Holdings and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow WGS

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about GeneDx Holdings stock

What does GeneDx Holdings do?

GeneDx Holdings trades on the Nasdaq under the ticker WGS. It is a mid cap company in the medical/nursing services industry, part of the healthcare sector, with a market value of about 2 billion dollars.

What is the ticker symbol for GeneDx Holdings?

GeneDx Holdings trades under the ticker WGS on the Nasdaq.

What is GeneDx Holdings's market cap?

GeneDx Holdings is a mid cap stock with a market cap of about 2 billion dollars.

How does GeneDx Holdings make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves WGS stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow WGS stock every day?

Add WGS to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow WGS daily

A free brief on GeneDx Holdings and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • BTSGU · BrightSpring Health Services
  • BTSG · BrightSpring Health Services
  • HIMS · Hims & Hers Health
  • CHE · Chemed

Similar stocks

  • BTSGUBrightSpring Health Services
  • BTSGBrightSpring Health Services
  • HIMSHims & Hers Health
  • CHEChemed

Compare WGS: WGS vs BTSGU, WGS vs BTSG, WGS vs HIMS

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed